CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma

Journal of Cutaneous Pathology

Volumn 37, Issue 7, 2010, Pages 744-750

  Kanner, William A ^a   Brill II, Louis B ^a   Patterson, James W ^a   Wick, Mark R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD99 PROTEIN, HUMAN; CELL ADHESION MOLECULE; CKAP4 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE METALLOENDOPEPTIDASE; MEMBRANE PROTEIN; TUMOR MARKER;

AGED; ARTICLE; BIOSYNTHESIS; DERMATOFIBROMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; METABOLISM; MIDDLE AGED; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MEMBRANE PROTEINS; MIDDLE AGED; NEPRILYSIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77952572193     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2010.01534.x     Document Type: Article

References (34)

1. Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue tumors, 5th ed.
2. Patterson JW, Wick MR. Nonmelanocytic tumors of the skin, Vol 4.
3. Mirza B, Weedon D. Atypical fibroxanthoma: a clinicopathological study of 89 cases. Australas J Dermatol 2005 46 : 235.
4. Monteagudo C, Calduch L, Navarro S, Joan-Figueroa A, Llombart-Bosch A. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. Am J Clin Pathol 2002 117 : 126.
5. Pernick NL, DaSilva M, Gangi MD, Crissman J, Adsay V. "Histiocytic markers" in melanoma. Mod Pathol 1999 12 : 1072.
6. Hultgren TL, DiMaio DJ. Immunohistochemical staining of CD10 in atypical fibroxanthomas. J Cutan Pathol 2007 34 : 415.
7. Weedon D, Williamson R, Mirza B. CD10, a useful marker for atypical fibroxanthomas. Am J Dermatopathol 2005 27 : 181.
8. Hall JM, Saenger JS, Fadare O. Diagnostic utility of P63 and CD10 in distinguishing cutaneous spindle cell/sarcomatoid squamous cell carcinomas and atypical fibroxanthomas. Int J Clin Exp Pathol 2008 1 : 524.
9. Hartel PH, Jackson J, Ducatman BS, Zhang P. CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker. J Cutan Pathol 2006 33 (Suppl. 2 24.
10. de Feraudy S, Mar N, McCalmont TH. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. Am J Surg Pathol 2008 32 : 1111.
11. Longacre TA, Smoller BR, Rouse RV. Atypical fibroxanthoma. multiple immunohistologic profiles. Am J Surg Pathol 1993 17 : 1199.
12. Pouryazdanparast P, Yu L, Cutlan JE, Olsen SH, Fullen DR, Ma L. Diagnostic value of CD163 in cutaneous spindle cell lesions. J Cutan Pathol 2009 36 : 859.
13. Dotto JE, Glusac EJ. P63 is a useful marker for cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2006 33 : 413.
14. Helwig EB. Atypical fibroxanthoma. Tex State J Med 1963 59 : 664.
15. Cooper JZ, Newman SR, Scott GA, Brown MD. Metastasizing atypical fibroxanthoma (cutaneous malignant histiocytoma): report of five cases. Dermatol Surg 2005 31 : 221 discussion 225.
16. Helwig EB, May D. Atypical fibroxanthoma of the skin with metastasis. Cancer 1986 57 : 368.
17. Giuffrida TJ, Kligora CJ, Goldstein GD. Localized cutaneous metastases from an atypical fibroxanthoma. Dermatol Surg 2004 30 : 1561.
18. Lum DJ, King AR. Peritoneal metastases from an atypical fibroxanthoma. Am J Surg Pathol 2006 30 : 1041.
19. Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one. J Cutan Pathol 2006 33 : 191.
20. Fretzin DF, Helwig EB. Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer 1973 31 : 1541.
21. Heintz PW, White CR Jr. Diagnosis: atypical fibroxanthoma or not? Evaluating spindle cell malignancies on sun damaged skin: a practical approach. Semin Cutan Med Surg 1999 18 : 78.
22. Wick MR, Fitzgibbon J, Swanson PE. Cutaneous sarcomas and sarcomatoid neoplasms of the skin. Semin Diagn Pathol 1993 10 : 148.
23. Wick MR, Swanson PE, Rocamora A. Recognition of malignant melanoma by monoclonal antibody HMB-45: an immunohistochemical study of 200 paraffin-embedded cutaneous tumors. J Cutan Pathol 1988 15 : 201.
24. Fisher C. Synovial sarcoma. Ann Diagn Pathol 1998 2 : 401.
25. Weidner N, Tjoe J. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 1994 18 : 486.
26. Zhang PJ, Barcos M, Stewart CC, Block AW, Sait S, Brooks JJ. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases. Mod Pathol 2000 13 : 452.
27. Ordi J, Romagosa C, Tavassoli FA, et al. CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors. Am J Surg Pathol 2003 27 : 178.
28. McCluggage WG, Oliva E, Herrington CS, McBride H, Young RH. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology 2003 43 : 144.
29. Xiao SY, Wang HL, Hart J, Fleming D, Beard MR. cDNA arrays and immunohistochemistry identification of CD10/ CALLA expression in hepatocellular carcinoma. Am J Pathol 2001 159 : 1415.
30. Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal tumors. Semin Diagn Pathol 2005 22 : 51.
31. Kanitakis J, Bourchany D, Claudy A. Expression of the CD10 antigen (neutral endopeptidase) by mesenchymal tumors of the skin. Anticancer Res 2000 20 : 3539.
32. Mathew RA, Schlauder SM, Calder KB, Morgan MB. CD117 immunoreactivity in atypical fibroxanthoma. Am J Dermatopathol 2008 30 : 34.
33. Jensen K, Wilkinson B, Wines N, Kossard S. Procollagen 1 expression in atypical fibroxanthoma and other tumors. J Cutan Pathol 2004 31 : 57.
34. McCalmont, T. Brother (and sister), can you spare the S100? (Editorial). J Cutan Pathol 2009 37 : 4.